223 related articles for article (PubMed ID: 23966559)
1. A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer.
Poole EM; Lee IM; Ridker PM; Buring JE; Hankinson SE; Tworoger SS
Am J Epidemiol; 2013 Oct; 178(8):1256-64. PubMed ID: 23966559
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies.
Karlson EW; Chibnik LB; Tworoger SS; Lee IM; Buring JE; Shadick NA; Manson JE; Costenbader KH
Arthritis Rheum; 2009 Mar; 60(3):641-52. PubMed ID: 19248103
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of Systemic Inflammation and Risk of Incident Hearing Loss.
Gupta S; Curhan SG; Curhan GC
Ear Hear; 2019; 40(4):981-989. PubMed ID: 30399011
[TBL] [Abstract][Full Text] [Related]
5. Plasma C-reactive protein and risk of breast cancer in two prospective studies and a meta-analysis.
Wang J; Lee IM; Tworoger SS; Buring JE; Ridker PM; Rosner B; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1199-206. PubMed ID: 25994740
[TBL] [Abstract][Full Text] [Related]
6. High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium.
Peres LC; Mallen AR; Townsend MK; Poole EM; Trabert B; Allen NE; Arslan AA; Dossus L; Fortner RT; Gram IT; Hartge P; Idahl A; Kaaks R; Kvaskoff M; Magliocco AM; Merritt MA; Quirós JR; Tjonneland A; Trichopoulou A; Tumino R; van Gils CH; Visvanathan K; Wentzensen N; Zeleniuch-Jacquotte A; Tworoger SS
Cancer Res; 2019 Oct; 79(20):5442-5451. PubMed ID: 31462430
[TBL] [Abstract][Full Text] [Related]
7. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Pinto L; Hartge P; Kemp T; Black A; Sherman ME; Brinton LA; Pfeiffer RM; Shiels MS; Chaturvedi AK; Hildesheim A; Wentzensen N
Gynecol Oncol; 2014 Nov; 135(2):297-304. PubMed ID: 25158036
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of C-reactive protein, interleukin-6 and tumor necrosis factor-α and risk of colorectal adenomas: a meta-analysis.
Zhang X; Liu S; Zhou Y
Oncotarget; 2016 Sep; 7(39):64371-64379. PubMed ID: 27608842
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of an Empirical Dietary Inflammatory Index.
Tabung FK; Smith-Warner SA; Chavarro JE; Wu K; Fuchs CS; Hu FB; Chan AT; Willett WC; Giovannucci EL
J Nutr; 2016 Aug; 146(8):1560-70. PubMed ID: 27358416
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression.
Chocano-Bedoya PO; Mirzaei F; O'Reilly EJ; Lucas M; Okereke OI; Hu FB; Rimm EB; Ascherio A
J Affect Disord; 2014 Jul; 163():25-32. PubMed ID: 24836084
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory markers and the risk of coronary heart disease in men and women.
Pai JK; Pischon T; Ma J; Manson JE; Hankinson SE; Joshipura K; Curhan GC; Rifai N; Cannuscio CC; Stampfer MJ; Rimm EB
N Engl J Med; 2004 Dec; 351(25):2599-610. PubMed ID: 15602020
[TBL] [Abstract][Full Text] [Related]
13. A Prospective Study of Inflammatory Markers and Risk of Endometriosis.
Mu F; Harris HR; Rich-Edwards JW; Hankinson SE; Rimm EB; Spiegelman D; Missmer SA
Am J Epidemiol; 2018 Mar; 187(3):515-522. PubMed ID: 28992341
[TBL] [Abstract][Full Text] [Related]
14. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
Seddon JM; George S; Rosner B; Rifai N
Arch Ophthalmol; 2005 Jun; 123(6):774-82. PubMed ID: 15955978
[TBL] [Abstract][Full Text] [Related]
15. Circulating Biomarkers of Inflammation and Ovarian Cancer Risk in the Nurses' Health Studies.
Peres LC; Townsend MK; Birmann BM; Conejo-Garcia JR; Kim Y; Kubzansky LD; Magpantay LI; Martinez-Maza O; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):710-718. PubMed ID: 33563649
[TBL] [Abstract][Full Text] [Related]
16. Plasma androgen concentrations and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Hankinson SE
Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).
Cesari M; Penninx BW; Newman AB; Kritchevsky SB; Nicklas BJ; Sutton-Tyrrell K; Tracy RP; Rubin SM; Harris TB; Pahor M
Am J Cardiol; 2003 Sep; 92(5):522-8. PubMed ID: 12943870
[TBL] [Abstract][Full Text] [Related]
18. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial.
Depalma RG; Hayes VW; Chow BK; Shamayeva G; May PE; Zacharski LR
J Vasc Surg; 2010 Jun; 51(6):1498-503. PubMed ID: 20304584
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of inflammatory biomarker levels and risk of early menopause.
Bertone-Johnson ER; Manson JE; Purdue-Smithe AC; Hankinson SE; Rosner BA; Whitcomb BW
Menopause; 2019 Jan; 26(1):32-38. PubMed ID: 29994968
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of plasma inflammatory markers and risk of colorectal cancer in men.
Song M; Wu K; Ogino S; Fuchs CS; Giovannucci EL; Chan AT
Br J Cancer; 2013 May; 108(9):1891-8. PubMed ID: 23591192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
